Free tool
Healthcare stocks
We cover 1,883 companies in the Healthcare sector. The median market value in the group is $694.69M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is −0.15%. 58% of the 962 with a 200-day average trade above it. Price change over the past year runs from −38.4% to +167.9% across the middle 80 percent of the group, with a median of +11.1%. Among those 1,000, 8 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,883 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| BHVN34.SA | BIOHAVEN LTDDRN | 23.68 BRL | 0.00% | −1.09% | −18.03% |
| PROK | ProKidney Corp. | $1.74 | +12.99% | −21.97% | −30.12% |
| EVO | Evotec SE | $1.95 | −0.51% | −38.68% | −44.13% |
| GMRS | GMR Solutions Inc. | $12.82 | −1.38% | −8.30% | −8.30% |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% |
| DHT-U.TO | DRI Healthcare Trust | $12.56 | +0.88% | +6.68% | +27.68% |
| EIKN | Eikon Therapeutics, Inc. | $11.98 | +26.24% | −20.13% | −20.13% |
| AQST | Aquestive Therapeutics, Inc. | $5.39 | +43.35% | −16.43% | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| CBIO | Crescent Biopharma, Inc. | $18.02 | +9.61% | +62.64% | +26.46% |
| LBIRD.PA | Lumibird SA | 25.80 EUR | −1.53% | +23.06% | +57.43% |
| 2HQ0.DE | Tilray Brands, Inc. | 4.07 EUR | +21.13% | −48.80% | −67.56% |
| CRMD | CorMedix Inc. | $8.39 | +14.15% | −31.00% | −40.66% |
| PRME | Prime Medicine, Inc. | $3.58 | +15.86% | +1.42% | +4.37% |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% |
| 4565.T | Nxera Pharma Co., Ltd. | 1,109.00 JPY | +27.47% | +31.40% | +22.68% |
| MDXG | MiMedx Group, Inc. | $4.42 | +1.38% | −31.79% | −38.35% |
| VSTM | Verastem, Inc. | $7.39 | +18.62% | +2.21% | −20.45% |
| TLRY.TO | Tilray Brands, Inc. | 6.46 CAD | +13.73% | −51.61% | +240.00% |
| CTNM | Contineum Therapeutics, Inc. | $17.02 | +20.20% | +49.43% | +70.03% |
| KIDS | OrthoPediatrics Corp. | $24.03 | +21.12% | +36.85% | +11.10% |
| IDX.AX | Integral Diagnostics Limited | 2.30 AUD | +10.05% | −7.10% | −19.60% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | 67,050.00 KRW | +2.21% | −19.02% | −16.94% |
| TLRY | Tilray Brands, Inc. | $4.64 | +15.14% | −52.26% | −66.13% |
| CTEV | Claritev Corporation | $37.57 | +65.73% | +10.86% | −47.71% |
| 6197.T | Solasto Corporation | 1,118.00 JPY | +0.63% | +30.15% | +136.68% |
| VALN | Valneva SE | $6.70 | +32.31% | −25.24% | −23.49% |
| DASA3.SA | Diagnósticos da América S.A. | 2.61 BRL | −1.51% | −41.74% | +93.33% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.37 AUD | +13.16% | −36.25% | −25.63% |
| VLA.PA | Valneva SE | 2.89 EUR | +31.25% | −23.68% | −24.48% |
| ICLR34.SA | ICON PLC DRN | 41.72 BRL | −2.07% | −17.97% | −14.33% |
| AUTL | Autolus Therapeutics plc | $2.33 | +60.69% | +24.60% | +48.41% |
| AYJ.DE | Valneva SE | 2.98 EUR | +35.29% | −23.93% | −21.89% |
| ARVN | Arvinas, Inc. | $9.32 | +13.66% | −18.74% | +15.35% |
| ALT | Altimmune, Inc. | $3.15 | +5.35% | −10.26% | −14.17% |
| MPLT | MapLight Therapeutics, Inc. | $12.86 | +4.47% | −23.32% | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $4.57 | +2.47% | −7.11% | +11.74% |
| 3034.T | Qol Holdings Co., Ltd. | 2,497.00 JPY | +12.88% | +21.60% | +24.35% |
| RGNX | REGENXBIO Inc. | $9.38 | −2.29% | −30.88% | +6.35% |
| CRW.L | Craneware plc | 1,272.00 GBP | +2.75% | −33.40% | −40.83% |
| EQS.PA | Equasens Société anonyme | 34.05 EUR | −1.02% | −24.08% | −25.98% |
| WEAV | Weave Communications, Inc. | $7.31 | +6.10% | +1.95% | −5.68% |
| EOLS | Evolus, Inc. | $8.78 | +41.16% | +30.65% | +15.83% |
| NAN.AX | Nanosonics Limited | 2.71 AUD | −13.69% | −30.87% | −39.91% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +11.78% | +178.25% | +259.94% |
| BWAY | BrainsWay Ltd. | $14.30 | −7.68% | +48.26% | +87.42% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | 2,062.00 JPY | −5.72% | −0.79% | +3.91% |
| ZURA | Zura Bio Limited | $5.99 | +8.12% | +7.93% | +177.31% |
| DCTH | Delcath Systems, Inc. | $16.40 | +41.99% | +64.82% | +49.91% |
| SPRY | ARS Pharmaceuticals, Inc. | $6.03 | +6.35% | −47.52% | −55.13% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% |
| OVID | Ovid Therapeutics Inc. | $2.88 | +22.03% | +63.64% | +128.57% |
| EVH | Evolent Health, Inc. | $4.92 | +31.55% | +26.48% | −48.86% |
| ENTX | Entera Bio Ltd. | $3.19 | −2.15% | +80.23% | +62.76% |
| CERS | Cerus Corporation | $2.74 | −6.16% | +39.09% | +109.16% |
| 005257.KS | GC Corp. | 16,630.00 KRW | +20.51% | −35.95% | −40.16% |
| 003850.KS | Boryung Corporation | 8,940.00 KRW | +18.10% | −4.39% | +9.00% |
| KYTX | Kyverna Therapeutics, Inc. | $8.61 | +14.95% | −1.82% | +133.33% |
| CABA | Cabaletta Bio, Inc. | $3.25 | +19.05% | +47.06% | +116.67% |
| FLGT | Fulgent Genetics, Inc. | $19.81 | +0.92% | −22.59% | −8.46% |
| SRTA | Strata Critical Medical, Inc. | $6.12 | +20.24% | +24.14% | +33.62% |
| AYA.AX | Artrya Limited | 5.03 AUD | +5.45% | −0.79% | +157.95% |
| TCMD | Tactile Systems Technology, Inc. | $23.51 | −15.25% | −14.20% | +78.78% |
| 2664.T | Cawachi Limited | 3,760.00 JPY | +8.20% | +28.43% | +38.25% |
| 137310.KS | SD Biosensor, Inc. | 6,140.00 KRW | +1.66% | −30.67% | −38.35% |
| 003090.KS | Daewoong Co., Ltd. | 17,280.00 KRW | +8.27% | −19.25% | −27.35% |
| BOI.PA | Boiron SA | 25.80 EUR | −5.84% | −14.29% | +21.99% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $4.24 | +19.44% | +119.69% | +64.34% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | 13,370.00 KRW | +23.80% | −43.35% | −40.58% |
| 7979.T | Shofu Inc. | 2,321.00 JPY | +6.76% | +30.43% | +21.34% |
| 4480.T | Medley, Inc. | 2,713.00 JPY | +30.12% | +15.94% | +9.22% |
| TOI | Starling Oncology Inc | $6.20 | +25.25% | +68.94% | +79.19% |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $7.23 | −6.10% | −16.90% | −41.46% |
| NPCE | NeuroPace, Inc. | $14.68 | −4.11% | −3.23% | +65.32% |
| 3151.T | Vital KSK Holdings, Inc. | 1,670.00 JPY | −2.51% | +21.29% | +40.44% |
| EVMN | Evommune, Inc. | $14.11 | +25.42% | −18.49% | −30.25% |
| CLPT | ClearPoint Neuro, Inc. | $16.37 | +12.66% | +16.68% | +53.85% |
| IMR.AX | Imricor Medical Systems, Inc. | 1.95 AUD | +0.78% | +18.96% | +40.43% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.04 EUR | +0.97% | −90.91% | −90.91% |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% |
| SENS | Senseonics Holdings, Inc. | $9.34 | +90.22% | +58.57% | +0.43% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | 0.81 EUR | +8.00% | +386.49% | +1198.08% |
| CGC | Canopy Growth Corporation | $1.04 | +15.77% | −13.03% | −31.46% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $7.43 | +21.80% | −1.85% | +40.72% |
| WEED.TO | Canopy Growth Corporation | 1.43 CAD | +13.49% | −12.80% | −31.25% |
| EDIT | Editas Medicine, Inc. | $3.18 | +21.37% | +55.12% | +19.10% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | 10.28 CAD | +20.23% | −1.72% | +43.78% |
| NRC | NRC Health | $22.00 | −1.52% | +23.14% | +45.92% |
| 4549.T | Eiken Chemical Co., Ltd. | 2,296.00 JPY | −8.71% | −3.54% | −5.16% |
| RLMD | Relmada Therapeutics, Inc. | $4.55 | −13.00% | +4.12% | +579.10% |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% |
| PNV.AX | PolyNovo Limited | 1.03 AUD | +17.05% | −17.60% | −23.99% |
| PACB | Pacific Biosciences of California, Inc. | $1.56 | +12.23% | −15.22% | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $8.38 | +18.70% | +22.82% | +21.09% |
| 317450.KS | MYUNGIN PHARM | 45,750.00 KRW | +14.09% | −25.73% | −55.96% |
| CAPR | Capricor Therapeutics, Inc. | $9.36 | +42.47% | −66.94% | +49.76% |
| AGY.L | Allergy Therapeutics plc | 5.60 GBP | −5.08% | −52.94% | −30.00% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | 3.45 BRL | +8.15% | −44.80% | −1.57% |
| QTTB | Q32 Bio Inc. | $16.18 | +2.99% | +370.35% | +840.70% |
| OCGN | Ocugen, Inc. | $1.41 | +13.71% | +2.17% | +35.58% |
| PRTA | Prothena Corporation plc | $9.25 | +8.06% | +0.54% | +8.06% |
| 005690.KS | Pharmicell Co., Ltd. | 10,850.00 KRW | +20.82% | −24.76% | −0.03% |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% |
| CVX.PA | Carvolix SA | 7.18 EUR | +17.70% | +293.42% | +293.42% |
| SGHT | Sight Sciences, Inc. | $8.37 | +57.92% | +11.90% | +97.87% |
| 001060.KS | JW Pharmaceutical Corporation | 26,850.00 KRW | +22.05% | +6.29% | +26.96% |
| KSI.TO | kneat.com, inc. | 6.50 CAD | +0.46% | +30.52% | +19.93% |
| BIOA | BioAge Labs, Inc. | $9.84 | −55.11% | −23.30% | +107.59% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $15.83 | +175.30% | +153.28% | −8.44% |
| MCTA | Charming Medical Limited | $29.36 | 0.00% | 0.00% | +319.36% |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% |
| AVIR | Atea Pharmaceuticals, Inc. | $5.51 | +22.17% | +58.33% | +53.06% |
| CARL | Carlsmed, Inc. | $16.18 | +31.44% | +39.12% | +16.40% |
| AVCT.L | Avacta Group Plc | 69.50 GBP | +0.72% | +20.87% | +26.36% |
| CMPX | Compass Therapeutics, Inc. | $2.43 | +19.12% | −53.00% | −25.91% |
| 001065.KS | JW Pharmaceutical Corporation | 22,800.00 KRW | +8.83% | −18.20% | −19.05% |
| LRMR | Larimar Therapeutics, Inc. | $4.17 | +8.88% | +20.17% | +6.92% |
| EYPT | EyePoint, Inc. | $4.99 | −58.28% | −71.45% | −57.85% |
| FRX.TO | Fennec Pharmaceuticals Inc. | 17.00 CAD | +21.86% | +63.30% | +36.00% |
| MASS | 908 Devices Inc. | $10.37 | +47.51% | +103.73% | +64.60% |
| CCRN | Cross Country Healthcare Inc | $13.25 | 0.00% | +64.39% | +0.38% |
| FENC | Fennec Pharmaceuticals Inc. | $12.17 | +22.43% | +58.46% | +34.62% |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | 91,600.00 KRW | +8.02% | −11.55% | −15.77% |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | 1,171.00 JPY | −3.86% | −23.00% | −19.86% |
| LXEO | Lexeo Therapeutics, Inc. | $5.01 | +14.12% | −47.87% | +3.30% |
| GALT | Galectin Therapeutics Inc. | $4.15 | +22.42% | +2.47% | +4.27% |
| XFOR | X4 Pharmaceuticals, Inc. | $4.17 | +6.11% | +7.20% | −1.42% |
| ENTA | Enanta Pharmaceuticals, Inc. | $14.15 | +12.21% | −1.87% | +65.89% |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% |
| FYB.DE | Formycon AG | 18.44 EUR | −2.64% | −29.35% | −25.04% |
| BLAU3.SA | Blau Farmacêutica S.A. | 9.07 BRL | +4.13% | −34.30% | −2.28% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | 531.00 JPY | +2.71% | −21.85% | −9.63% |
| LNA.PA | LNA Santé SA | 33.90 EUR | −2.87% | +38.37% | +11.88% |
| M12.DE | M1 Kliniken AG | 18.36 EUR | −2.86% | +1.10% | +37.84% |
| RCKT | Rocket Pharmaceuticals, Inc. | $3.66 | +16.56% | +5.78% | +10.24% |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | 2,623.00 JPY | +5.13% | +30.89% | +27.04% |
| FHTX | Foghorn Therapeutics Inc. | $6.69 | +30.41% | +28.90% | +23.66% |
| OFIX | Orthofix Medical Inc. | $9.75 | −20.47% | −34.30% | −34.30% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +30.42% |
| IPSC | Century Therapeutics, Inc. | $2.14 | +4.39% | +115.08% | +315.53% |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% |
| UPB | Upstream Bio, Inc. | $7.13 | +11.41% | −73.66% | −57.31% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| TKNO | Alpha Teknova, Inc. | $7.22 | +41.85% | +85.13% | +62.25% |
| E2NO34.SA | Enovis Corporation | 34.59 BRL | +7.86% | +12.74% | −19.24% |
| MOBI | Mobia Medical, Inc. | $11.65 | +8.68% | −0.85% | −0.85% |
| AUNA | Auna SA | $5.23 | +0.58% | +9.87% | −16.85% |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | 1.92 BRL | +214.75% | −29.41% | −33.79% |
| 4886.T | ASKA Pharmaceutical Holdings Co.,Ltd. | 2,138.00 JPY | −3.87% | +5.30% | −10.08% |
| VOX.WA | Voxel S.A. | 134.20 PLN | +6.85% | +10.36% | −18.11% |
| CGS.AX | Cogstate Limited | 3.20 AUD | +22.88% | +39.52% | +85.76% |
| 368A.T | KITAZATO CORPORATION | 1,495.00 JPY | +7.55% | −1.89% | −1.33% |
| ACL.AX | Australian Clinical Labs Limited | 2.81 AUD | +15.64% | +4.75% | +5.46% |
| SLP | Simulations Plus, Inc. | $18.41 | +0.44% | +1.66% | +28.20% |
| AGEN | Agenus Inc. | $8.25 | +25.00% | +155.42% | +81.72% |
| PALI | Palisade Bio, Inc. | $2.13 | +5.45% | −14.80% | +222.73% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.89 | −15.80% | +183.94% | +113.74% |
| 2395.T | Shin Nippon Biomedical Laboratories, Ltd. | 1,403.00 JPY | +5.25% | −11.69% | −13.02% |
| VHI.TO | Vitalhub Corp. | 8.11 CAD | +16.69% | −14.99% | −36.39% |
| LYEL | Lyell Immunopharma, Inc. | $15.49 | +19.25% | −46.55% | +37.32% |
| N3B.F | Anbio Biotechnology | 6.40 EUR | −24.26% | −62.13% | −83.42% |
| DMAC | DiaMedica Therapeutics Inc. | $6.70 | +0.90% | −15.51% | +12.04% |
| CATX | Perspective Therapeutics, Inc. | $3.16 | +10.10% | +13.26% | −12.47% |
| 262A.T | INTERMESTIC INC | 1,857.00 JPY | −1.85% | −3.38% | −28.96% |
| 3733.T | Software Service, Inc. | 12,520.00 JPY | +10.50% | −6.64% | −14.23% |
| IFRX | InflaRx N.V. | $2.42 | +43.20% | +122.02% | +142.00% |
| ALCLS.PA | Cellectis S.A. | 2.94 EUR | +16.59% | −30.30% | +27.74% |
| OPT.L | Optima Health plc | 240.50 GBP | +1.48% | +20.85% | +9.32% |
| STRO | Sutro Biopharma, Inc. | $21.43 | −9.69% | +95.53% | +138.11% |
| VMD | Viemed Healthcare, Inc. | $9.33 | −21.73% | +29.22% | +29.94% |
| SABS | SAB Biotherapeutics, Inc. | $3.88 | +12.46% | +2.92% | +83.02% |
| 219A.T | HEARTSEED INC | 2,435.00 JPY | +48.48% | +34.90% | −30.13% |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | 12.09 BRL | +4.22% | +1.62% | +20.56% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| IKT | Inhibikase Therapeutics, Inc. | $2.49 | +7.79% | +27.69% | +39.11% |
| 377740.KS | BioNote, Inc. | 4,750.00 KRW | +6.86% | −10.21% | −13.05% |
| CLLS | Cellectis S.A. | $3.42 | +20.42% | −28.75% | +28.09% |
| ABEO | Abeona Therapeutics Inc. | $6.01 | −0.17% | +13.18% | −12.90% |
| NNNN | Anbio Biotechnology | $7.72 | −23.94% | −73.81% | −83.55% |
| OCA.AX | Oceania Healthcare Limited | 0.66 AUD | +4.80% | −18.13% | +9.17% |
| 019170.KS | Shinpoong Pharmaceutical Co.,Ltd | 8,810.00 KRW | +21.18% | −36.80% | −30.36% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | 9.36 AUD | −2.40% | −26.36% | −24.94% |
| 197A.T | TAUNS LABORATORIES INC. | 504.00 JPY | +4.56% | −0.59% | −11.13% |
| IMRX | Immuneering Corporation | $5.15 | +21.46% | −22.21% | −0.77% |
| P2OD34.SA | Insulet Corporation | 24.68 BRL | −12.58% | −26.20% | −26.20% |
| PRQR | ProQR Therapeutics N.V. | $2.35 | +33.52% | +18.09% | +6.33% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | 14,450.00 KRW | +18.93% | −62.41% | −40.38% |
| 005250.KS | GC Corp. | 10,000.00 KRW | +10.62% | −35.88% | −32.75% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| AVH.AX | AVITA Medical, Inc. | 2.87 AUD | +117.05% | +160.45% | +106.12% |
| ILM1.DE | Medios AG | 10.92 EUR | −1.62% | −25.61% | −26.32% |
| VNDA | Vanda Pharmaceuticals Inc. | $5.35 | +3.68% | −35.15% | +15.80% |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% |
| MATD3.SA | Hospital Mater Dei S.A. | 5.01 BRL | +1.62% | −2.72% | +11.78% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | 13.50 EUR | +8.87% | −48.77% | +47.70% |
| OBIO | Orchestra BioMed Holdings, Inc. | $5.26 | +36.27% | +22.04% | +85.21% |
| IRD | Opus Genetics, Inc. | $3.80 | +11.44% | +79.25% | +216.67% |
| VICO.ST | Vicore Pharma Holding AB (publ) | 10.74 SEK | −0.74% | −2.19% | −1.29% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| RAC.AX | Racura Oncology Ltd | 2.23 AUD | +12.06% | −22.30% | +87.39% |
| RNAC | Cartesian Therapeutics, Inc. | $10.19 | +33.20% | +50.74% | −4.09% |
| YDES | YD Bio Ltd | $4.34 | +88.70% | −63.83% | −63.83% |
| 7779.T | CYBERDYNE Inc. | 232.00 JPY | +5.45% | +20.83% | +12.08% |
| TMCI | Treace Medical Concepts, Inc. | $4.72 | +17.71% | +88.80% | −36.39% |
| EBS | Emergent BioSolutions Inc. | $5.97 | −18.33% | −52.28% | −30.50% |
| FATE | Fate Therapeutics, Inc. Common Stock | $2.57 | +10.78% | +159.60% | +129.46% |
| BCYC | Bicycle Therapeutics plc | $4.36 | +10.53% | −34.81% | −37.79% |
| TLSI | TriSalus Life Sciences, Inc. | $4.93 | +13.86% | −19.18% | −3.33% |
| 4554.T | Fuji Pharma Co., Ltd. | 1,843.00 JPY | −2.85% | −2.52% | +26.29% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| AMRN | Amarin Corporation plc | $14.38 | +3.05% | +4.77% | −7.08% |
| AVXL | Anavex Life Sciences Corp. | $3.24 | +26.07% | −11.96% | −65.71% |
| 4894.T | Cuorips Inc. | 5,720.00 JPY | +35.06% | −8.04% | −15.38% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −9.00% | −21.91% | +16.89% |
| MYGN | Myriad Genetics, Inc. | $3.12 | −41.35% | −49.19% | −47.39% |
| TRDA | Entrada Therapeutics, Inc. | $7.00 | +20.07% | −30.35% | +23.24% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| FULC | Fulcrum Therapeutics, Inc. | $3.86 | +3.76% | −64.65% | −41.78% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | 4,110.00 KRW | +12.14% | +7.31% | +26.14% |
| NMRA | Neumora Therapeutics, Inc. | $1.56 | −7.14% | −6.02% | −11.36% |
| 0120G0.KS | Samyang Biopharm | 54,100.00 KRW | +52.39% | +4.04% | +79.14% |
| TTRX | Turn Therapeutics Inc. | $9.63 | +25.06% | +105.33% | +37.57% |
| CV | CapsoVision, Inc. | $5.82 | −12.08% | −43.16% | +46.97% |
| ANIK | Anika Therapeutics, Inc. | $21.68 | +43.10% | +131.87% | +136.17% |
| 7777.T | 3-D Matrix, Ltd. | 361.00 JPY | +13.88% | −0.55% | +68.69% |
| EDT.TO | Spectral Medical Inc. | 1.33 CAD | −2.92% | −3.62% | −6.99% |
| EMBC | Embecta Corp. | $4.96 | +38.16% | −56.84% | −64.70% |
| LCTX | Lineage Cell Therapeutics, Inc. | $1.12 | +4.67% | −31.71% | −8.20% |
| PIHLIS.HE | Pihlajalinna Oyj | 10.92 EUR | +5.61% | −21.46% | −28.38% |
| SION | Sionna Therapeutics, Inc. | $6.17 | −86.75% | −84.26% | −75.45% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| PYXS | Pyxis Oncology, Inc. | $3.34 | +14.78% | +190.43% | +145.59% |
| AFP.AX | AFT Pharmaceuticals Limited | 3.60 AUD | −8.86% | +20.00% | +50.00% |
| TSTL.L | Tristel plc | 425.00 GBP | +1.19% | −2.84% | +19.76% |
| WHWK | Whitehawk Therapeutics, Inc. | $4.84 | +31.52% | +98.36% | +167.40% |
| SRZN | Surrozen, Inc. | $23.71 | +22.22% | +10.02% | +107.98% |
| ALXO | ALX Oncology Holdings Inc. | $1.98 | −0.50% | +72.17% | +65.00% |
| 6078.T | Value HR Co.,Ltd. | 1,631.00 JPY | +4.48% | +6.53% | +6.39% |
| ELDN | Eledon Pharmaceuticals, Inc. | $3.35 | −1.47% | +106.79% | +29.84% |
| CGEN | Compugen Ltd. | $2.84 | +25.66% | +83.23% | +93.20% |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% |
| 950210.KS | Prestige BioPharma Limited | 6,150.00 KRW | +10.81% | −54.65% | −55.91% |
| GLSI | Greenwich LifeSciences, Inc. | $18.23 | +35.54% | −6.37% | +56.21% |
| ELMD | Electromed, Inc. | $31.77 | −19.53% | +15.99% | +28.26% |
| IVVD | Invivyd, Inc. | $0.90 | +52.06% | −63.93% | +3.52% |
| RXST | RxSight, Inc. | $6.38 | +5.45% | −38.54% | −25.38% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $4.20 | +22.81% | −30.00% | +178.15% |
| ALEC | Alector, Inc. | $2.46 | +61.84% | +60.78% | +2.50% |
| TNG.PA | Transgene SA | 0.81 EUR | +12.57% | −15.34% | −22.50% |
| 7749.T | Medikit Co.,Ltd. | 2,899.00 JPY | +3.39% | −0.57% | +18.68% |
| 4820.T | EM Systems Co., Ltd. | 602.00 JPY | +6.17% | −22.62% | −18.79% |
| 170900.KS | Dong-A ST Co., Ltd. | 37,600.00 KRW | +11.90% | −22.29% | −10.09% |
| PRN.TO | Profound Medical Corp. | 9.90 CAD | −3.60% | −6.16% | +59.16% |
| NAGE | Niagen Bioscience, Inc. | $3.30 | +0.30% | −47.20% | −66.22% |
| SLGL | Sol-Gel Technologies Ltd. | $79.43 | −4.38% | +88.45% | +261.87% |
| PROF | Profound Medical Corp. | $7.11 | −1.93% | −7.18% | +57.30% |
| NERV | Minerva Neurosciences, Inc. | $5.43 | +26.87% | +38.52% | +129.11% |
| ADAG | Adagene Inc. | $3.85 | +3.22% | +109.24% | +75.80% |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% |
| CPH.TO | Cipher Pharmaceuticals Inc. | 14.10 CAD | −13.55% | −5.37% | −7.84% |
| 6823.T | Rion Co., Ltd. | 3,355.00 JPY | +3.23% | +28.29% | +29.62% |
| MGNX | MacroGenics, Inc. Common Stock | $4.04 | +4.94% | +150.93% | +134.88% |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | 24.54 BRL | −15.38% | +9.87% | +18.69% |
| ALMDT.PA | Median Technologies SA | 4.57 EUR | +15.84% | +3.98% | +90.42% |
| OSUR | OraSure Technologies, Inc. | $3.71 | −7.71% | +55.88% | +11.08% |
| R2AR34.SA | Ultragenyx Pharmaceutical Inc. | 13.33 BRL | −16.48% | +11.74% | +11.74% |
| LAB | Standard BioTools Inc. | $0.65 | −17.49% | −48.68% | −49.08% |
| 7071.T | Amvis Holdings, Inc. | 416.00 JPY | +8.05% | −9.76% | −31.35% |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% |
| ACB | Aurora Cannabis Inc. | $4.00 | +47.06% | −7.83% | −24.95% |
| ACB.TO | Aurora Cannabis Inc. | 5.54 CAD | +44.65% | −6.73% | −24.93% |
| AKBA | Akebia Therapeutics, Inc. | $0.91 | −28.62% | −41.52% | −69.88% |
| CRDL | Cardiol Therapeutics Inc. | $2.14 | +78.33% | +115.29% | +91.07% |
| CRDL.TO | Cardiol Therapeutics Inc. | 2.97 CAD | +74.71% | +118.38% | +90.38% |
| SPL.AX | Starpharma Holdings Limited | 0.73 AUD | −2.03% | +98.63% | +437.04% |
| 4548.T | Seikagaku Corporation | 719.00 JPY | −5.27% | +2.45% | +13.11% |
| TTX.AX | Tetratherix Limited | 6.43 AUD | −14.83% | +94.85% | +56.83% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | 1,380.00 JPY | +6.73% | +3.16% | +14.45% |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% |
| SY | So-Young International Inc. | $2.40 | +22.45% | −10.11% | −38.93% |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% |
| 4593.T | Healios K.K. | 286.00 JPY | +34.91% | +1.78% | −41.63% |
| PEPG | PepGen Inc. | $3.22 | +75.96% | −55.09% | +159.68% |
| RNA | Prosensa Holding B.V. Ordinary Shares | $13.85 | +20.54% | −6.10% | −6.10% |
| CLN.WA | Celon Pharma S.A. | 22.20 PLN | +5.21% | +8.82% | −3.06% |
| 6062.T | Charm Care Corporation | 1,394.00 JPY | +0.29% | +6.98% | +33.46% |
| DTIL | Precision BioSciences, Inc. | $8.49 | +18.41% | +107.07% | +69.46% |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $13.64 | +37.22% | −17.58% | −57.61% |
| HLS.AX | Healius Limited | 0.45 AUD | +20.00% | −50.55% | −50.55% |
| XLY.TO | Auxly Cannabis Group Inc. | 3.13 CAD | +19.92% | +2058.62% | +1919.35% |
| ALERS.PA | Eurobio Scientific Société anonyme | 19.80 EUR | −6.60% | −18.01% | −21.89% |
| 145720.KS | Dentium CO., LTD | 37,050.00 KRW | +1.79% | −21.91% | −35.04% |
| TARA | Protara Therapeutics, Inc. | $3.91 | −0.76% | −27.32% | +21.05% |
| TSND.TO | TerrAscend Corp. | 0.85 CAD | +23.19% | −19.05% | −44.44% |
| STIM | Neuronetics, Inc. | $3.00 | +60.43% | +108.33% | −10.71% |
| UTMD | Utah Medical Products, Inc. | $70.89 | −0.10% | +26.08% | +17.76% |
| ORGO | Organogenesis Holdings Inc. | $1.75 | −30.83% | −62.24% | −63.84% |
| IMUX | Immunic, Inc. | $16.49 | +23.61% | +182.85% | +92.87% |
| CHRS | Coherus Oncology, Inc. | $1.45 | +0.69% | +5.84% | +27.19% |
| NGEN | NervGen Pharma Corp. | $2.21 | +37.27% | −62.41% | −8.30% |
| HITI | High Tide Inc. | $2.52 | +22.33% | −10.00% | −30.00% |
| SIGA | SIGA Technologies, Inc. | $3.07 | −8.08% | −44.65% | −57.93% |
| KROS | Keros Therapeutics, Inc. | $11.12 | +10.43% | −40.02% | −28.35% |
| 3183.T | WIN-Partners Co., Ltd. | 1,277.00 JPY | −5.90% | −0.26% | −0.56% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% |
| SPOK | Spok Holdings, Inc. | $10.42 | −4.36% | −15.28% | −36.39% |
| NBP | NovaBridge Biosciences | $1.87 | +6.86% | −56.21% | −58.44% |
| ABOS | Acumen Pharmaceuticals, Inc. | $2.99 | +31.14% | +48.02% | +115.11% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | 847.00 JPY | +40.00% | +44.79% | +75.00% |
| STIL.ST | Stille AB | 225.00 SEK | −5.06% | +16.58% | −4.26% |
| VYGR | Voyager Therapeutics, Inc. | $3.46 | +13.82% | −14.14% | +1.17% |
| DERM | Journey Medical Corporation | $7.55 | +19.57% | +1.28% | +0.87% |
| CUE | Cue Biopharma, Inc. | $28.85 | −4.63% | +185.36% | +16.42% |
| ANTX | AN2 Therapeutics, Inc. | $5.53 | +17.66% | +398.20% | +385.09% |
| ZJYL | Jin Medical International Ltd. | $2.79 | +45.31% | −38.00% | −82.97% |
| 4595.T | Mizuho Medy Co.,Ltd. | 1,721.00 JPY | +1.59% | −0.58% | +11.63% |
| AOTI.L | AOTI, Inc. | 142.50 GBP | +35.71% | +418.18% | +159.09% |
| ACOG | Alpha Cognition Inc. | $9.41 | +11.89% | +44.77% | +14.20% |
| 7679.T | YAKUODO HOLDINGS Co., Ltd. | 1,675.00 JPY | −7.30% | −21.14% | −25.53% |
| ICE.WA | Medinice S.A. | 72.30 PLN | −6.35% | +330.36% | +595.19% |
| NORDH.OL | Nordhealth AS | 24.40 NOK | 0.00% | −32.22% | −32.22% |
| PDEX | Pro-Dex, Inc. | $63.84 | +13.31% | +69.25% | +40.31% |
| 096760.KS | JW Holdings Corporation | 4,050.00 KRW | +12.81% | +21.23% | +28.35% |
| ARMP | Armata Pharmaceuticals, Inc. | $5.45 | +15.22% | −16.92% | +123.36% |
| 9273.T | Koa Shoji Holdings Co.,Ltd. | 767.00 JPY | −2.79% | −10.19% | +0.52% |
| N2VC34.SA | NovoCure Limited | 8.94 BRL | +0.45% | +67.42% | +67.42% |
| KRRO | Korro Bio, Inc. | $13.68 | +30.29% | +69.94% | −36.61% |
| MSCL.TO | Satellos Bioscience Inc. | 13.08 CAD | −2.10% | +55.71% | +81.67% |
| PLX | Protalix BioTherapeutics, Inc. | $2.48 | +6.44% | +42.53% | +55.00% |
| LIK.DE | LIMES Schlosskliniken AG | 570.00 EUR | −0.87% | +58.33% | +70.66% |
| AMWL | American Well Corporation | $11.92 | +7.48% | +145.77% | +71.51% |
| MSLE | Satellos Bioscience Inc. | $9.36 | −1.06% | +50.87% | +77.27% |
| AIRS | AirSculpt Technologies, Inc. | $2.72 | −41.63% | +47.03% | −57.30% |
| ORIOLA.HE | Oriola Oyj | 0.90 EUR | −0.33% | −20.66% | −21.98% |
| NKTX | Nkarta, Inc. | $2.63 | +18.47% | +40.64% | +17.41% |
| MVF.AX | Monash IVF Group Limited | 0.69 AUD | +0.73% | −6.34% | +0.35% |
| 5592.T | Kusurinomadoguchi, Inc. | 2,721.00 JPY | +12.76% | +2.69% | −27.59% |
| BLC.PA | Bastide Le Confort Médical SA | 22.30 EUR | −2.83% | −6.50% | −16.32% |
| HUMA | Humacyte, Inc. | $0.68 | +8.02% | −30.09% | −55.45% |
| AIDX.TO | Healwell AI Inc. | 0.79 CAD | +20.77% | −6.55% | −40.08% |
| 007575.KS | Ilyang Pharmaceutical Co.,Ltd | 8,140.00 KRW | +13.37% | −37.29% | −36.46% |
| XGN | Exagen Inc. | $7.67 | +72.36% | +26.99% | −19.69% |
| LUCD | Lucid Diagnostics Inc. | $0.97 | +6.20% | −13.33% | −22.96% |
| DR.TO | Medical Facilities Corporation | 15.73 CAD | −13.09% | +1.39% | +11.47% |
| PEB.AX | Pacific Edge Limited | 0.20 AUD | −9.09% | +25.00% | +60.00% |
| MYX.AX | Mayne Pharma Group Limited | 3.15 AUD | +19.32% | −1.25% | −37.38% |
| 286A.T | EUCALIA INC | 820.00 JPY | +2.12% | −14.14% | −10.77% |
| 5038.T | eWeLL Co.,Ltd. | 2,133.00 JPY | +2.06% | −16.78% | −22.27% |
| CDXS | Codexis, Inc. | $1.65 | +10.00% | +2.48% | −38.20% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,892.00 JPY | +4.82% | +10.10% | +21.78% |
| 008490.KS | Suheung Co., Ltd. | 22,050.00 KRW | +12.44% | +2.56% | −24.62% |
| CARA.ST | Carasent AB (publ) | 25.25 SEK | +1.00% | −5.78% | −10.62% |
| CNTN | Canton Strategic Holdings, Inc. | $2.23 | +9.31% | −34.02% | −55.04% |
| OGI | Organigram Global Inc. | $1.26 | +32.77% | −27.17% | −24.55% |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | 7.46 BRL | +19.36% | −12.03% | −1.92% |
| OGI.TO | Organigram Global Inc. | 1.74 CAD | +32.82% | −26.58% | −24.68% |
| SPRB | Spruce Biosciences, Inc. | $61.48 | +47.79% | −32.22% | +721.93% |
| LFCR | Lifecore Biomedical, Inc. | $4.65 | +5.92% | −39.92% | −38.25% |
| WW | WW International, Inc. | $17.60 | +27.91% | −44.02% | −45.96% |
| QSI | Quantum-Si incorporated | $0.79 | +3.89% | −31.84% | −31.84% |
| 4320.T | CE Holdings Co.,Ltd. | 1,652.00 JPY | −3.05% | +57.63% | +139.84% |
| FLERIE.ST | Flerie AB (publ) | 19.25 SEK | −3.02% | −40.94% | −48.05% |
| SANION.ST | Saniona AB (publ) | 11.83 SEK | −15.32% | −43.93% | −12.37% |
| BIOM3.SA | Biomm S.A. | 6.44 BRL | +9.15% | −9.30% | +0.63% |
| MOLN | Molecular Partners AG | $4.45 | +16.19% | +5.45% | +18.67% |
| MENS | Jyong Biotech Ltd. | $2.24 | −6.28% | −34.31% | −95.62% |
| DXRX.L | Diaceutics PLC | 143.50 GBP | +8.71% | +11.67% | +4.36% |
| 005500.KS | Samjin Pharmaceuticals Co., Ltd. | 18,240.00 KRW | +7.23% | −5.64% | +0.32% |
| KZIA | Kazia Therapeutics Limited | $14.60 | +15.05% | +192.00% | +86.94% |
| PGC.AX | Paragon Care Limited | 0.14 AUD | +13.60% | −35.45% | −58.24% |
| ALCGM.PA | Cegedim SA | 10.26 EUR | +1.38% | −25.92% | −4.56% |
| VME.DE | Viromed Medical AG | 6.50 EUR | −15.03% | +71.96% | +85.71% |
| FOCL | EDAP TMS S.A. | $4.41 | −27.23% | +29.71% | +179.11% |
| NYXH | Nyxoah SA | $1.62 | +13.29% | −64.00% | −73.74% |
| ALSEN.PA | Sensorion SA | 0.28 EUR | −0.71% | −17.01% | −14.20% |
| MDWD | MediWound Ltd. | $12.70 | −13.13% | −31.05% | −25.29% |
| 504A.T | Innovacell Inc. | 570.00 JPY | +3.07% | −45.71% | −45.71% |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% |
| NYKD.OL | Nykode Therapeutics AS | 4.64 NOK | +45.68% | +96.94% | +204.86% |
| PHO.OL | Photocure ASA | 54.00 NOK | −0.18% | −24.90% | −13.46% |
| LFMD | LifeMD, Inc. | $3.24 | −15.62% | −7.16% | −49.45% |
| TNYA | Tenaya Therapeutics, Inc. | $0.70 | −7.91% | −5.28% | −36.71% |
| OKUR | OnKure Therapeutics, Inc. | $3.80 | −3.80% | +28.38% | +35.71% |
| 3939.T | Kanamic Network Co.,LTD | 520.00 JPY | +3.59% | +1.56% | +6.05% |
| ENE.WA | Centrum Medyczne ENEL-MED S.A. | 20.00 PLN | −0.99% | +11.11% | +16.28% |
| SPRC | SciSparc Ltd. | $6.74 | +26.45% | −46.51% | −82.42% |
| EBR.AX | EBR Systems, Inc. | 0.29 AUD | +4.36% | −68.63% | −78.74% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| S2B.WA | Syn2bio S.A. | 63.00 PLN | −9.12% | +76.47% | +76.47% |
| OTLK | Outlook Therapeutics, Inc. | $0.62 | −31.05% | −5.56% | −73.76% |
| 003520.KS | Yungjin Pharm. Co., Ltd. | 1,139.00 KRW | +0.44% | −43.75% | −43.89% |
| OWLT | Owlet, Inc. | $5.16 | −0.19% | −68.09% | −28.43% |
| NRXP | NRx Pharmaceuticals, Inc. | $3.46 | −2.26% | +32.06% | +34.11% |
| EQ | Equillium, Inc. | $2.36 | +1.72% | +54.25% | +23.56% |
| AARD | Aardvark Therapeutics, Inc. | $6.81 | +6.07% | −48.37% | −24.25% |
| MRC.WA | Mercator Medical S.A. | 60.40 PLN | +18.43% | +52.53% | +35.88% |
| UNCY | Unicycive Therapeutics, Inc. | $5.43 | +9.92% | −6.38% | +27.17% |
| OCC.AX | Orthocell Limited | 0.76 AUD | +6.29% | −32.14% | −36.67% |
| CRNO-B.ST | Cereno Scientific AB (publ) | 4.71 SEK | +0.13% | −32.04% | −53.59% |
| KRMD | KORU Medical Systems, Inc. | $3.21 | −19.95% | −42.78% | −24.47% |
| INGN | Inogen, Inc. | $5.56 | −13.40% | −16.14% | −29.89% |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% |
| MIST | Milestone Pharmaceuticals Inc. | $1.18 | +10.28% | −42.44% | −33.33% |
| LENZ | LENZ Therapeutics, Inc. | $4.78 | −18.71% | −70.12% | −87.21% |
| CNTB | Connect Biopharma Holdings Limited | $2.33 | +12.02% | −7.54% | +30.90% |
| GENO.ST | Genovis AB (publ.) | 20.15 SEK | +2.81% | −7.36% | −16.91% |
| V5P.F | Vytrus Biotech, S.A. | 17.60 EUR | +1.73% | +67.62% | +225.93% |
| CRRX.TO | CareRx Corporation | 3.20 CAD | −6.43% | −17.08% | +8.40% |
| OPRX | OptimizeRx Corporation | $7.75 | +22.24% | −37.60% | −55.79% |
| INDP | Indaptus Therapeutics, Inc. | $1.14 | −34.10% | −58.39% | −82.19% |
| EKF.L | EKF Diagnostics Holdings plc | 24.70 GBP | −5.00% | −6.97% | −15.56% |
| IMDX | Insight Molecular Diagnostics Inc. | $4.30 | −6.72% | −39.94% | +73.39% |
| STXS | Stereotaxis, Inc. | $1.45 | +13.28% | −37.50% | −49.48% |
| EMPG | Empro Group Inc | $17.36 | 0.00% | 0.00% | +76.60% |
| LOVE.TO | Cannara Biotech Inc. | 1.99 CAD | +5.29% | +11.80% | +11.80% |
| ARX.AX | Aroa Biosurgery Limited | 0.56 AUD | −3.45% | −23.29% | −13.85% |
| 4599.T | StemRIM | 350.00 JPY | +21.53% | +32.08% | +14.75% |
| PAX.ST | Paxman AB (publ) | 57.50 SEK | +26.37% | +2.68% | −21.45% |
| MXCT | MaxCyte, Inc. | $1.31 | +24.76% | −15.48% | −6.43% |
| TLSA | Tiziana Life Sciences Ltd | $1.09 | +12.37% | −31.87% | −41.08% |
| SCLP.L | Scancell Holdings plc | 9.70 GBP | −2.02% | −2.02% | −7.62% |
| SLV.WA | Selvita S.A. | 28.60 PLN | +7.52% | −35.29% | −9.21% |
| HURA | TuHURA Biosciences, Inc. | $2.13 | 0.00% | +184.00% | −26.55% |
| HPHA.DE | Heidelberg Pharma AG | 2.52 EUR | −2.70% | +0.80% | −31.15% |
| NYR.AX | Nyrada Inc. | 0.76 AUD | +40.74% | −35.86% | +210.20% |
| 004310.KS | Hyundai Pharmaceutical Co., Ltd. | 6,020.00 KRW | +22.61% | −33.31% | +51.26% |
| INO | Inovio Pharmaceuticals, Inc. | $1.30 | +26.21% | −23.08% | −47.15% |
| 001630.KS | Chong Kun Dang Holdings Corp. | 38,900.00 KRW | +4.15% | −11.74% | −17.31% |
| 7600.T | Japan Medical Dynamic Marketing, INC. | 810.00 JPY | −10.00% | +67.91% | +59.26% |
| ADCT | ADC Therapeutics SA | $1.05 | −5.41% | −70.17% | −67.39% |
| 016580.KS | Whan In Pharm Co.,Ltd. | 10,020.00 KRW | +1.11% | −7.73% | −5.20% |
| VTVT | vTv Therapeutics Inc. | $33.57 | +8.01% | −15.23% | +106.71% |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% |
| 9158.T | CUC Inc. | 717.00 JPY | −7.96% | −11.70% | −37.22% |
| 102460.KS | REYON Pharmaceutical Co., Ltd. | 9,860.00 KRW | +0.41% | −10.85% | −8.36% |
| MVIR.ST | Medivir AB (publ) | 2.08 SEK | +14.29% | +351.19% | +4.73% |
| XI3.F | Bioceltix S.A. | 20.40 EUR | +7.59% | −16.22% | −28.67% |
| 3649.T | FINDEX Inc. | 860.00 JPY | −0.58% | −6.01% | +4.84% |
| ENGN | enGene Therapeutics Inc. | $1.95 | +10.80% | −77.97% | −55.07% |
| BDTX | Black Diamond Therapeutics, Inc. | $2.27 | +28.98% | −8.84% | −20.91% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% |
| PMN | ProMIS Neurosciences, Inc. | $14.46 | −0.41% | +102.52% | +9.13% |
| APYX | Apyx Medical Corporation | $3.05 | −20.98% | −12.86% | +54.04% |
| CBUS | Cibus, Inc. | $1.68 | −13.40% | −10.64% | +27.27% |
| VANI | Vivani Medical, Inc. | $1.42 | +8.02% | +11.42% | +15.98% |
| QTRX | Quanterix Corporation | $2.68 | −23.21% | −58.32% | −41.87% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | 74.00 PLN | −0.80% | −1.33% | +80.49% |
| GUTS | Fractyl Health, Inc. | $0.74 | +1.95% | −67.24% | −25.55% |
| 234080.KS | JW Lifescience Corporation | 11,130.00 KRW | +2.87% | −9.35% | +1.24% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| BMEA | Biomea Fusion, Inc. | $1.71 | +36.80% | +27.61% | −8.06% |
| GNLX | Genelux Corporation | $2.73 | −6.51% | −40.00% | −25.00% |
| 4538.T | Fuso Pharmaceutical Industries,Ltd. | 2,310.00 JPY | +1.90% | +1.94% | +11.15% |
| DXB.AX | Dimerix Limited | 0.29 AUD | +20.83% | −47.27% | −34.83% |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% |
| CRAD-B.ST | C-Rad AB (publ) | 35.30 SEK | −4.08% | +11.00% | +6.49% |
| NTHI | NeOnc Technologies Holdings, Inc. | $4.56 | +30.66% | −48.65% | −29.30% |
| HAMLET-B.ST | Hamlet BioPharma AB (publ) | 6.10 SEK | −17.57% | +7.02% | −0.81% |
| 003220.KS | Daewon Pharmaceutical Co., Ltd. | 7,770.00 KRW | +7.32% | −35.25% | −39.54% |
| BCX.WA | Bioceltix S.A. | 80.50 PLN | −17.01% | 0.00% | −20.77% |
| JYNT | The Joint Corp. | $8.54 | −1.04% | −3.50% | −20.19% |
| A2ZT34.SA | Azenta, Inc. | 14.16 BRL | +16.64% | +50.80% | +50.80% |
| ONE.AX | Oneview Healthcare PLC | 0.19 AUD | +26.67% | −51.90% | −15.56% |
| SCP.WA | Scope Fluidics S.A. | 140.20 PLN | +19.83% | +0.29% | −9.90% |
| EMV.AX | EMVision Medical Devices Ltd | 1.73 AUD | +11.61% | −2.26% | −13.93% |
| SDI.AX | SDI Ltd | 1.40 AUD | 0.00% | +51.08% | +60.41% |
| HCAT | Health Catalyst, Inc. | $1.59 | −25.70% | −30.26% | −56.91% |
| S84.F | Scope Fluidics S.A. | 27.90 EUR | +19.74% | −25.50% | −10.43% |
| RANI | Rani Therapeutics Holdings, Inc. | $0.84 | +2.74% | −38.13% | +49.45% |
| ACW.AX | Actinogen Medical Limited | 0.04 AUD | +7.69% | −36.36% | +44.83% |
| MDP.TO | Medexus Pharmaceuticals Inc. | 5.18 CAD | +7.02% | +67.64% | +66.56% |
| RVU.WA | Ryvu Therapeutics S.A. | 18.40 PLN | +22.67% | −32.23% | −36.99% |
| QUCY | Quantum Cyber N.V. | $1.38 | +26.15% | +18.53% | −15.12% |
| COYA | Coya Therapeutics, Inc. | $4.87 | +21.75% | −13.81% | −25.76% |
| GBT.PA | Guerbet SA | 7.92 EUR | +3.80% | −46.41% | −61.92% |
| SEER | Seer, Inc. | $2.02 | −5.61% | +10.99% | −1.94% |
| 3154.T | Medius Holdings Co., Ltd. | 808.00 JPY | +2.41% | −0.74% | −2.42% |
| 4889.T | Renascience Inc. | 1,309.00 JPY | −8.59% | −8.40% | −40.80% |
| CCLD | CareCloud, Inc. | $2.64 | +11.86% | −9.28% | −28.84% |
| 2929.T | Pharma Foods International Co., Ltd. | 615.00 JPY | +5.22% | −5.90% | −37.82% |
| NAUT | Nautilus Biotechnology, Inc. | $0.94 | −21.88% | −50.92% | +33.34% |
| SYNACT.ST | SynAct Pharma AB | 19.66 SEK | +12.99% | −12.43% | +10.82% |
| FARON.HE | Faron Pharmaceuticals Oy | 0.48 EUR | −0.92% | −78.79% | −79.42% |
| AZT.OL | ArcticZymes Technologies ASA | 20.80 NOK | +5.05% | −1.89% | −27.02% |
| T2ND34.SA | Tandem Diabetes Care, Inc. | 7.33 BRL | +22.37% | +41.78% | +41.78% |
| ALCJ.PA | Crossject Société Anonyme | 1.48 EUR | −0.67% | −31.00% | −2.63% |
| FARN.L | Faron Pharmaceuticals Oy | 41.00 GBP | −4.65% | −78.97% | −79.24% |
| BNR | Burning Rock Biotech Limited | $10.44 | +13.60% | −46.95% | +22.54% |
| ONCY | Oncolytics Biotech Inc. | $0.86 | +8.30% | −12.69% | −19.28% |
| 007570.KS | Ilyang Pharmaceutical Co.,Ltd | 8,360.00 KRW | +1.58% | −35.94% | −32.69% |
| 3544.T | Satudora Holdings Co.,Ltd. | 1,249.00 JPY | −0.64% | +54.37% | +51.42% |
| 003120.KS | Ilsung Is Co., Ltd. | 20,850.00 KRW | +1.71% | −2.80% | −4.68% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.